Literature DB >> 19571773

Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.

Sarah M R Wille1, Elke Raes, Pirjo Lillsunde, Teemu Gunnar, Marleen Laloup, Nele Samyn, Asbjørg S Christophersen, Manfred R Moeller, Karin P Hammer, Alain G Verstraete.   

Abstract

In recent years, the interest in the use of oral fluid as a biological matrix has increased significantly, particularly for detecting driving under the influence of drugs (DUID). In this study, the relationship between the oral fluid and the blood concentrations of drugs of abuse in drivers suspected of DUID is discussed. Blood and oral fluid samples were collected from drivers suspected of DUID or stopped during random controls by the police in Belgium, Germany, Finland, and Norway for the ROSITA-2 project. The blood samples were analyzed by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS), sometimes preceded by immunoassay screening of blood or urine samples. The oral fluid samples were analyzed by GC-MS or LC-MS(/MS). Scatter plots and trend lines of the blood and oral fluid concentrations and the median, mean, range, and SD of the oral fluid to blood (OF:B) ratios were calculated for amphetamines, benzodiazepines, cocaine, opiates, and Delta(9)-2 tetrahydrocannabinol. The ratios found in this study were comparable with those that were published previously, but the range was wider. The OF:B ratios of basic drugs such as amphetamines, cocaine, and opiates were >1 [amphetamine: median (range) 13 (0.5-182), methylenedioxyamphetamine: 4 (1-15), methylenedioxymethamphetamine: 6 (0.9-88), methamphetamine: 5 (2-23), cocaine: 22 (4-119), benzoylecgonine: 1 (0.2-11), morphine: 2 (0.8-6), and codeine: 10 (0.8-39)]. The ratios for benzodiazepines were very low, as could be expected as they are highly protein bound and weakly acidic, leading to low oral fluid concentrations [diazepam: 0.02 (0.01-0.15), nordiazepam: 0.04 (0.01-0.23), oxazepam: 0.05 (0.03-0.14), and temazepam: 0.1 (0.06-0.54)]. For tetrahydrocannabinol, an OF:B ratio of 15 was found (range 0.01-569). In this study, the time of last administration, the dose, and the route of administration were unknown. Nevertheless, the data reflect the variability of the OF:B ratios in drivers thought to be under the influence of drugs. The wide range of the ratios, however, does not allow reliable calculation of the blood concentrations from oral fluid concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571773     DOI: 10.1097/FTD.0b013e3181ae46ea

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  14 in total

1.  Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.

Authors:  Joseph J Palamar; Alberto Salomone; Enrico Gerace; Daniele Di Corcia; Marco Vincenti; Charles M Cleland
Journal:  Int J Drug Policy       Date:  2017-08-12

2.  Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.

Authors:  Dayong Lee; Ryan Vandrey; Garry Milman; Mateus Bergamaschi; Damodara R Mendu; Jeannie A Murray; Allan J Barnes; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-07-06       Impact factor: 4.142

3.  Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.

Authors:  Anna Pehrsson; Tom Blencowe; Kari Vimpari; Antti Impinen; Teemu Gunnar; Pirjo Lillsunde
Journal:  Int J Legal Med       Date:  2010-07-23       Impact factor: 2.686

4.  Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Marta Concheiro; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2016-01-22       Impact factor: 2.395

5.  Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.

Authors:  Garry Milman; David M Schwope; Eugene W Schwilke; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-29       Impact factor: 8.327

6.  A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.

Authors:  Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

7.  Use of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid.

Authors:  Hallvard Gjerde; Asbjørg S Christophersen; Inger S Moan; Borghild Yttredal; J Michael Walsh; Per T Normann; Jørg Mørland
Journal:  J Occup Med Toxicol       Date:  2010-06-15       Impact factor: 2.646

8.  Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-08-10       Impact factor: 3.345

Review 9.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

10.  Positivity to Cocaine and/or Benzoylecgonine in Confirmation Analyses for On-Road Tests in Spain.

Authors:  Francisco Herrera-Gómez; Eduardo Gutiérrez-Abejón; Mercedes García-Mingo; F Javier Álvarez
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.